Another approach was to conjugate a uPAR-specific targeting peptide onto magnetic nanoparticles for the development of theranostic agents for diagnosis and image-guided therapy of uPAR-overexpressing primary and metastatic tumor lesions (Hansen et al., 2013). Here, PLAUR is linked to neoplasm.